A detailed history of New Edge Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, New Edge Wealth, LLC holds 29,362 shares of AZN stock, worth $2.34 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
29,362
Previous 29,175 0.64%
Holding current value
$2.34 Million
Previous $1.98 Million 15.84%
% of portfolio
0.05%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$66.81 - $80.83 $12,493 - $15,115
187 Added 0.64%
29,362 $2.29 Million
Q1 2024

May 06, 2024

SELL
$61.03 - $69.57 $145,800 - $166,202
-2,389 Reduced 7.57%
29,175 $1.98 Million
Q4 2023

Jan 29, 2024

BUY
$61.89 - $69.28 $156,581 - $175,278
2,530 Added 8.71%
31,564 $2.13 Million
Q3 2023

Nov 08, 2023

BUY
$64.85 - $71.7 $179,958 - $198,967
2,775 Added 10.57%
29,034 $1.97 Million
Q2 2023

Aug 09, 2023

SELL
$69.91 - $75.81 $192,671 - $208,932
-2,756 Reduced 9.5%
26,259 $1.88 Million
Q1 2023

May 08, 2023

SELL
$63.15 - $71.6 $57,213 - $64,869
-906 Reduced 3.03%
29,015 $2.01 Million
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $78,604 - $102,138
1,450 Added 5.09%
29,921 $2.03 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $245,482 - $628,522
4,630 Added 19.42%
28,471 $1.56 Million
Q2 2022

Aug 09, 2022

BUY
$59.26 - $71.14 $1.03 Million - $1.23 Million
17,330 Added 266.16%
23,841 $1.58 Million
Q1 2022

May 10, 2022

SELL
$55.72 - $67.12 $954,539 - $1.15 Million
-17,131 Reduced 72.46%
6,511 $432,000
Q4 2021

Jan 31, 2022

SELL
$54.02 - $63.83 $1.51 Million - $1.79 Million
-28,036 Reduced 54.25%
23,642 $1.38 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $2.55 Million - $2.79 Million
45,891 Added 793.0%
51,678 $3.1 Million
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $43,384 - $53,921
896 Added 18.32%
5,787 $347,000
Q1 2021

May 13, 2021

BUY
$47.16 - $54.44 $230,659 - $266,266
4,891 New
4,891 $243,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track New Edge Wealth, LLC Portfolio

Follow New Edge Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Wealth, LLC with notifications on news.